Abstract:Abstract Background The Autism Sequencing Consortium identified 102 high-confidence autism spectrum disorder (ASD) genes, showing that individuals with ASD and with potentially damaging single nucleotide variation (pdSNV) in these genes had lower cognitive levels and delayed age at walking, when compared to ASD participants without pdSNV. Here, we made use of a Swedish sample of individuals with ASD (called PAGES, for Population-Based Autism Genetics & Environment Study) to evaluate the frequency of pdSNV and their impact on medical and psychiatric phenotypes, using an epidemiological frame and universal health reporting. We then combine findings with those for potentially damaging copy number variation (pdCNV). Methods SNV and CNV calls were generated from whole-exome sequencing and chromosome microarray data, respectively. Birth and medical register data were used to collect phenotypes. Results Of 808 individuals assessed by sequencing, 69 (9%) had pdSNV in the 102 ASC genes, and 144 (18%) had pdSNV in the 102 ASC genes or in a larger set of curated neurodevelopmental genes (from the Deciphering Developmental Disorders study, the gene2phenotype database, and the Radboud University gene lists). Three or more individuals had pdSNV in GRIN2B , POGZ , SATB1 , DYNC1H1 , SCN8A, or CREBBP . In comparison, out of the 996 individuals from whom CNV were called, 105 (11%) carried one or more pdCNV, including four or more individuals with CNV in the recurrent 15q11q13, 22q11.2, and 16p11.2 loci. Carriers of pdSNV were more likely to have intellectual disability (ID) and epilepsy, while carriers of pdCNV showed increased rates of congenital anomalies and scholastic skill disorders. Carriers of either pdSNV or pdCNV were more likely to have ID, scholastic skill disorders, and epilepsy. Limitations The cohort only included individuals with autistic disorder, the more severe form of ASD, and phenotypes are defined from medical registers. Not all genes studied are definitively ASD genes, and we did not have de novo information to aid in classification. Conclusions In this epidemiological sample, rare pdSNV were more common than pdCNV and the combined yield of potentially damaging variation was substantial at 27%. The results provide compelling rationale for the use of high-throughout sequencing as part of routine clinical workup for ASD and support the development of precision medicine in ASD.

Association between rare, genetic variants linked to autism and ultrasonography fetal anomalies in children with autism spectrum disorder

Association of genetic variants with autism spectrum disorder in Japanese children revealed by targeted sequencing

Common genetic variants on 5p14.1 associate with autism spectrum disorders

Autism genome-wide copy number variation reveals ubiquitin and neuronal genes

Common risk variants identified in autism spectrum disorder

Identification of genetic variants and their causal association underlying autism spectrum disorder

Rare pathogenic variants identified in whole exome sequencing of monozygotic twins with autism spectrum disorders

Synthesis of genetic association studies on autism spectrum disorders using a genetic model-free approach

Prenatal ultrasound and childhood autism: long-term follow-up after a randomized controlled trial of first- vs second-trimester ultrasound

Prenatal, perinatal, and neonatal risk factors of autism spectrum disorder

Neonatal risk factors associated with autism spectrum disorders: an umbrella review

The Genetic Architecture of Autism Spectrum Disorders (asds) and the Potential Importance of Common Regulatory Genetic Variants

Numerous Confounders Affecting the Alleged Association Between Cesarean Deliveries Under General Anesthesia and Autism Spectrum Disorder

Integration of Transcriptome and Exome Genotyping Identifies Significant Variants with Autism Spectrum Disorder

Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder

Predictive Ability of Ultrasound on Neonatal Diagnoses and Consequences on Prenatal Care Utilization

Commonly used genomic arrays may lose information due to imperfect coverage of discovered variants for autism spectrum disorder

The genetic landscape of autism spectrum disorder in the Middle Eastern population

Analysis of recent shared ancestry in a familial cohort identifies coding and noncoding autism spectrum disorder variants

Networks of Neuronal Genes Affected by Common and Rare Variants in Autism Spectrum Disorders

Genome Sequencing Identifies 13 Novel Candidate Risk Genes for Autism Spectrum Disorder in a Qatari Cohort